Comprehensive World Health Organization guidelines for preventive chemotherapy and mass drug administration of soil-transmitted helminthiasis. Official WHO recommendations for Mebendazole treatment programs.
The World Health Organization (WHO) has established comprehensive guidelines for the control of soil-transmitted helminthiasis (STH) through preventive chemotherapy and mass drug administration (MDA). These guidelines aim to reduce morbidity and transmission of STH infections worldwide.
People at risk globally
World population affected
Countries implementing MDA
Target coverage by 2030
Preventive chemotherapy involves the administration of medicines to entire populations or at-risk groups, regardless of individual infection status, to reduce morbidity and transmission.
Focus on soil-transmitted helminthiasis (STH) caused by Ascaris lumbricoides, Trichuris trichiura, and hookworms (Ancylostoma duodenale and Necator americanus).
School-age children (5-14 years), preschool children (1-4 years), women of reproductive age (15-49 years), and adults in high-risk occupations.
Mebendazole 500mg single dose is the WHO-recommended first-line treatment for STH infections due to efficacy, safety, and cost-effectiveness.
| Target Group | Drug | Dosage | Frequency |
|---|---|---|---|
| School-age children | Mebendazole | 500mg single dose | Annual or biannual |
| Preschool children | Mebendazole | 500mg single dose | Annual or biannual |
| Women of reproductive age | Mebendazole | 500mg single dose | Annual |
| Adults in high-risk areas | Mebendazole | 500mg single dose | Annual |
WHO recommends annual treatment in areas with 20-50% prevalence and twice-yearly treatment in areas with >50% prevalence for STH infections.
Conduct prevalence mapping to identify high-risk areas and establish surveillance systems to monitor program impact and drug efficacy.
Implement health education programs to promote hygiene, sanitation, and understanding of deworming benefits.
Engage community leaders, teachers, and parents to ensure high treatment coverage and compliance.
Establish robust M&E systems to track coverage, impact, and drug resistance patterns.
Identify all schools in target areas, enroll students, and establish treatment schedules.
Train teachers on drug administration, side effect management, and record keeping.
Distribute Mebendazole tablets to schools with proper storage and administration protocols.
Establish reporting systems for treatment coverage, adverse events, and program monitoring.
75% treatment coverage of school-age children in endemic countries
Eliminate STH as a public health problem in children in endemic countries
Eliminate STH morbidity in all endemic countries through universal coverage
Regular monitoring of prevalence, intensity, and coverage to track progress
| Formulation: | 500mg chewable tablets |
| Quality: | WHO prequalified, GMP certified |
| Storage: | Room temperature, protected from moisture |
| Shelf Life: | 36 months |
| Packaging: | Bulk bottles, blister packs |
| Distribution: | Temperature-controlled logistics |
| Gastrointestinal: | Abdominal pain (2-5%), diarrhea (1-3%) |
| Central Nervous: | Headache (<1%), dizziness (<1%) |
| Allergic: | Rare (<0.1%), rash, urticaria |
| Severity: | Generally mild and self-limiting |
| Management: | Supportive care, usually no treatment needed |
Percentage of target population receiving treatment (target: >75%)
Reduction in STH prevalence over time (target: <5% moderate/heavy infections)
Monitoring of side effects and adverse events (target: <1% serious events)
Improvement in knowledge about STH and prevention (target: >80% awareness)
Implement WHO-compliant deworming programs with WHO-prequalified Mebendazole. Get complete support for preventive chemotherapy and mass drug administration initiatives.
Comprehensive guide to intestinal worms, symptoms, and treatment options with Mebendazole.
Worm TypesPediatric formulation of Mebendazole for children and WHO-recommended dosing for school programs.
100mg ProductHealthcare professional resources including dosing guidelines and treatment protocols.
HCP ResourcesOur team is ready to provide you with the best pharmaceutical products and support